Teva Announces At-Risk Settlement and Positive Phase II Data for LupusBy Jessica SwansonOctober 30, 2013 Teva Pharmaceuticals announced a settlement with Pfizer PFE for its at-risk launch of Protonix in 2008. The $1.6 billion settlement…